Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3357 studies found for:    Open Studies | "Carcinoma"
Show Display Options
Rank Status Study
21 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib
22 Recruiting Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma
Condition: Advanced Lung Squamous Carcinoma
Interventions: Biological: Endostar;   Drug: Docetaxel;   Drug: Cisplatin
23 Recruiting Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma
Condition: Liver Cell Carcinoma Non-resectable
Intervention:
24 Recruiting Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Procedure: laser ablation (LA)
25 Recruiting Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)
Condition: Neuroendocrine Carcinoma
Intervention: Drug: Everolimus , temozolomide
26 Recruiting TCR-Redirected T Cell Infusions to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation
Condition: Hepatocellular Carcinoma
Intervention: Other: Biological: HBV antigen specific TCR redirected T cell
27 Recruiting Molecular Determinants for Therapy Response on Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: Sunitinib, Pazopanib, Bevacizumab, Everolimus...
28 Recruiting Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Doxorubicin;   Drug: Best Standard of Care
29 Not yet recruiting Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
Condition: Metastatic Renal Cell Carcinoma.
Intervention:
30 Recruiting Post Marketing Surveillance for ICE-SENSE™3 a Cryotherapy Treatment of Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Device: ICESENSE3™
31 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
32 Not yet recruiting Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma
Condition: Pulmonary Large Cell Neuroendocrine Carcinoma
Interventions: Drug: etoposide plus carboplatin;   Drug: Paclitaxel plus carboplatin
33 Recruiting Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: Proton Beam Radiotherapy;   Drug: Sorafenib
34 Recruiting Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.
Condition: Advanced Hepatocellular Carcinoma With c-MET Dysregulation
Intervention: Drug: INC280
35 Recruiting Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Radiation: carbon-ion radiotherapy alone;   Radiation: proton plus carbon-ion radiotherapy
36 Recruiting Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)
Condition: Carcinoma, Merkel Cell
Intervention: Drug: Avelumab
37 Recruiting Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)
Condition: Renal Cell Carcinoma
Intervention: Radiation: ARREST-study
38 Recruiting Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Drug: MK-3475
39 Recruiting TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Radiation: TheraSphere
40 Recruiting No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Traditional RFA;   Procedure: No-touch RFA

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.